πŸ‡ΊπŸ‡Έ FDA
Patent

US 7109245

Vasoconstrictor cannabinoid analogs

granted A61KA61K31/047A61K31/09

Quick answer

US patent 7109245 (Vasoconstrictor cannabinoid analogs) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon Sep 14 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as Represented by the Secretary of the Department of Health and Human Services
Grant date
Tue Sep 19 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 14 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
24
CPC classes
A61K, A61K31/047, A61K31/09, A61P, A61P7/04